Skip to content

Gyre Therapeutics, Inc.: filings

Every Gyre Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-07fiscal Q2 2026541450001193125-26-340448
10-Q2026-05-08fiscal Q1 2026531040001193125-26-214676
10-K2026-03-13fiscal FY 2025541080001193125-26-106251
10-Q2025-11-07fiscal Q3 2025521450001193125-25-272383
10-Q2025-08-11fiscal Q2 2025521410000950170-25-106644
10-Q2025-05-09fiscal Q1 2025531060000950170-25-068089
10-K2025-03-17fiscal FY 2024571130000950170-25-040279
10-Q2024-11-13fiscal Q3 2024491380000950170-24-126306
10-Q2024-08-13fiscal Q2 2024491340000950170-24-096159
10-Q2024-05-13fiscal Q1 202448950000950170-24-058642
10-K2024-03-27fiscal FY 2023511010000950170-24-037242
10-Q2023-10-26fiscal Q3 202333980000950170-23-055695
10-Q2023-08-14fiscal Q2 202334960000950170-23-042218
10-Q2023-05-15fiscal Q1 202334700001564590-23-007276
10-K2023-03-30fiscal FY 202236690001564590-23-004830
10-Q2022-11-14fiscal Q3 2022361040001564590-22-037555
10-Q2022-08-15fiscal Q2 202236990001564590-22-029487
10-Q2022-05-09fiscal Q1 202232650001564590-22-018775
10-K2022-03-31fiscal FY 202135680001564590-22-012877
10-Q2021-11-12fiscal Q3 202136960001564590-21-056450
10-Q2021-08-05fiscal Q2 202137960001564590-21-041373
10-Q2021-05-06fiscal Q1 202137730001564590-21-024728
10-K2021-03-04fiscal FY 202035690001564590-21-010823
10-Q2020-11-05fiscal Q3 202035920001564590-20-051083
10-Q2020-08-06fiscal Q2 202036900001564590-20-037483
10-Q2020-05-11fiscal Q1 202036710001564590-20-023982
10-K2020-02-20fiscal FY 201938700001564590-20-005546
10-Q2019-11-07fiscal Q3 201935910001564590-19-041706
10-Q2019-08-01fiscal Q2 201934860001564590-19-027987
10-Q2019-05-02fiscal Q1 201934660001564590-19-015316
10-K2019-03-08fiscal FY 201837740001564590-19-006879
10-Q2018-11-01fiscal Q3 201833820001564590-18-026288
10-Q2018-08-02fiscal Q2 201833840001564590-18-018950
10-Q2018-05-03fiscal Q1 201827580001564590-18-010740
10-K2018-03-19fiscal FY 201730630001564590-18-006216
10-Q2017-11-02fiscal Q3 201727730001564590-17-021284
10-Q2017-08-03fiscal Q2 201727720001564590-17-015413
10-Q2017-05-11fiscal Q1 201726520001564590-17-010578
10-K2017-03-08fiscal FY 201631610001564590-17-003722
10-Q2016-11-03fiscal Q3 201628700001564590-16-027394
10-Q2016-08-04fiscal Q2 201626640001564590-16-022517
10-Q2016-05-05fiscal Q1 201624490001193125-16-579998
10-K2016-03-09fiscal FY 201530960001193125-16-498295
10-Q2015-11-05fiscal Q3 201526630001193125-15-368527
10-Q2015-07-31fiscal Q2 201527720001193125-15-272118
10-Q2015-05-07fiscal Q1 201527550001193125-15-176701
10-K2015-03-16fiscal FY 2014371190001193125-15-093871
10-Q2014-11-06fiscal Q3 201429760001193125-14-400415
10-Q2014-08-07fiscal Q2 201432820001193125-14-300016
10-Q2014-05-08fiscal Q1 201432640001193125-14-189770
10-K2014-03-14fiscal FY 2013421390001193125-14-099974
10-Q2013-11-06fiscal Q3 201335970001193125-13-429542
10-Q2013-08-07fiscal Q2 201335970001193125-13-324131
10-Q2013-05-08fiscal Q1 201335720001193125-13-207383
10-K2013-03-15fiscal FY 2012431640001193125-13-109464
10-Q2012-11-08fiscal Q3 201234980001193125-12-460294
10-Q2012-08-09fiscal Q2 201234980001193125-12-347071
10-Q2012-05-09fiscal Q1 201233680001193125-12-222293
10-K2012-03-06fiscal FY 201134910001193125-12-099259
10-Q2011-11-03fiscal Q3 201133920001193125-11-294601
10-Q2011-08-09fiscal Q2 201133920001193125-11-216664

Inspect the source

Entity
Gyre Therapeutics, Inc. / CIK 0001124105
Captured
2026-09-20T07:40:18.545Z
SEC response SHA-256
76d6d577c67b9fd5657091e03be7ffe01a1cac0d3d9b5ad24843327a50d791e0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001124105.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))